Table 1. Patient characteristics.
| hs-CRPa (n = 484) |
IL-6b (n = 563) |
Calprotectinb (n = 543) |
Fibrinogenc (n = 700) |
C3c (n = 698) |
|
|---|---|---|---|---|---|
| Age | 64 ± 9 | 64 ± 9 | 64 ± 9 | 65 ± 9 | 65 ± 9 |
| Male sex | 386 (80) | 446 (79) | 430 (79) | 558 (80) | 557 (80) |
| Prior MI | 442 (91) | 518 (92) | 499 (92) | 626 (89) | 624 (89) |
| Prior PCI/CABG | 471 (97) | 544 (97) | 524 (97) | 672 (96) | 670 (96) |
| Prior Stroke | 25 (5) | 25 (4) | 25 (5) | 37 (5) | 37 (5) |
| Diabetes | 107 (22) | 140 (25) | 135 (25) | 218 (31) | 218 (31) |
| Renal failured | 66 (14) | 77 (14) | 76 (14) | 102 (15) | 102 (15) |
| Antihypertensive treatment | 437 (90) | 509 (91) | 493 (91) | 636 (91) | 635 (91) |
| Statin treatment | 448 (93) | 519 (92) | 501 (92) | 635 (91) | 634 (91) |
| Current smoking | 98 (20) | 117 (21) | 113 (21) | 150 (21) | 150 (22) |
| Systolic BP (mmHg) | 142 ± 20 | 142 ± 21 | 142 ± 20 | 142 ± 21 | 142 ± 21 |
| Diastolic BP (mmHg) | 83 ± 11 | 83 ± 11 | 83 ± 11 | 83 ± 11 | 83 ± 11 |
| Body mass index (kg/m2) | 27.6 ± 4.3 | 27.7 ± 4.4 | 27.8 ± 4.4 | 27.9 ± 4.3 | 27.9 ± 4.4 |
| Creatinine (mM) | 81 (71–93.5) | 81 (71–93) | 81 (71–93) | 81 (71–93.5) | 81 (71–94) |
Data are presented as mean ± SD, median (IQR), or n (%).Abbreviations: BMI, body mass index; BP, blood pressure; CABG, coronary artery bypass graft surgery; MI, myocardial infarction; PCI, percutaneous coronary intervention.
a Data on prior stroke, antihypertensive treatment, statin treatment, BP, and BMI were missing in 3, 1, 1, 25, and 2 individuals, respectively.
b Data on prior stroke, antihypertensive treatment, statin treatment, current smoking, BP, and BMI were missing in 4, 1, 1, 1, 28, and 2 individuals, respectively.
c Data on prior stroke, antihypertensive treatment, statin treatment, current smoking, BP, and BMI were missing in 6, 2, 3, 1, 30, and 2 individuals, respectively.
d Estimated glomerular filtration rate ≤60 ml/min.